Get the Stockscreener App
2.57
4.10%
-0.11
After Hours:
2.54
-0.03
-1.17%
Rani Therapeutics Holdings Inc Stock (RANI) Forecast
The Rani Therapeutics Holdings Inc (RANI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.2585, representing a +104.61% increase from the current price of $2.57. The highest analyst price target is $7.5143, and the lowest is $3.0026.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RANI Price Target
Average 3.8189
(+48.59% Upside)
Is Rani Therapeutics Holdings Inc (RANI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.00 | Neutral |
| STOCH(9,6) | 38.73 | Neutral |
| STOCHRSI(14) | 50.44 | Neutral |
| MACD(12,26) | 0.0266 | Buy |
| ADX(14) | 26.14 | Buy |
| William %R | -68.21 | Neutral |
| CCI(14) | 51.74 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.465
Buy
|
2.4987
Buy
|
| MA20 |
2.338
Buy
|
2.4438
Buy
|
| MA50 |
2.5533
Buy
|
2.6095
Sell
|
| MA100 |
3.0897
Sell
|
3.0117
Sell
|
| MA200 |
3.7296
Sell
|
3.3428
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, RANI could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 5 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on RANI, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 52 indicates that RANI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 38.73 indicates that RANI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 50.44 indicates that RANI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.14 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 51.74 indicates that RANI is still overbought but not to an extreme extent.
Long-term RANI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Rani Therapeutics Holdings Inc financial reports and earnings history, Rani Therapeutics Holdings Inc (RANI) stock could reach $6.3071 by 2030, $46.72 by 2040 and $63.15 by 2050. See the projected annual prices until 2050 of the Rani Therapeutics Holdings Inc stock below:
- Rani Therapeutics Holdings Inc (RANI) is expected to reach an average price of $23.32 in 2035, with a high prediction of $24.03 and a low estimate of $23.64. This indicates an $807.49% rise from the last recorded price of $2.57.
- Rani Therapeutics Holdings Inc (RANI) stock is projected to chart a bullish course in 2040, with an average price target of $47.00, representing an $1,729% surge from its current level. The forecast ranges from a conservative $47.58 to a sky-high $46.72.
- Our analysts predict Rani Therapeutics Holdings Inc (RANI) to jump 1,121% by 2045, soaring from $31.66 to an average price of $31.39, potentially reaching $32.46. While $31.66 is the low estimate, the potential upside is significant.
- Rani Therapeutics Holdings Inc (RANI) stock is expected to climb by 2050, reaching an average of $61.70, a $2,301% jump from its current level. However, a wide range of estimates exists, with high and low targets of $63.15 and $61.78, respectively, highlighting the market's uncertainty.
Rani Therapeutics Holdings Inc Stock (RANI) Year by Year Forecast
Rani Therapeutics Holdings Inc Stock (RANI) Price Forecast for 2024
Our forecast for RANI stock price in 2024 now indicates an average price target of $12.99 with a high forecast of $24.99 and a low forecast of $0.9757. The average prediction reflects an increase of +405.26% from the last recorded price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2024 | $4.1509 | $3.0026 | $7.5143 | +61.51% |
| December, 2024 | $2.7042 | $2.5842 | $4.6792 | +5.22% |
Rani Therapeutics Holdings Inc Stock (RANI) Price Forecast for 2025
Rani Therapeutics Holdings Inc Stock (RANI) is expected to reach an average price of $2.5021 in 2025, with a high prediction of $4.8808 and a low estimate of $0.1235. This indicates an -2.64% fall from the last recorded price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.1257 | $0.1333 | $4.8808 | -56.20% |
| February, 2025 | $0.8189 | $0.2223 | $2.2223 | -68.14% |
| March, 2025 | $0.8422 | $0.2678 | $3.9038 | -67.23% |
| April, 2025 | $2.0037 | $0.5705 | $3.4614 | -22.04% |
| May, 2025 | $0.3469 | $0.2469 | $3.692 | -86.50% |
| June, 2025 | $0.0102 | $0.1415 | $1.6418 | -99.61% |
| July, 2025 | $1.5383 | $0.1235 | $2.085 | -40.14% |
| August, 2025 | $1.9351 | $2.4251 | $2.2867 | -24.71% |
| September, 2025 | $0.2419 | $0.4119 | $0.6614 | -90.59% |
| October, 2025 | $1.4903 | $1.0052 | $1.8036 | -42.01% |
| November, 2025 | $2.3071 | $1.812 | $1.9171 | -10.23% |
| December, 2025 | $1.2555 | $1.3355 | $1.9188 | -51.15% |
Rani Therapeutics Holdings Inc Stock (RANI) Price Forecast for 2026
The predicted value for Rani Therapeutics Holdings Inc (RANI) in 2026 is set at an average of $2.4794. Estimates vary from a peak of $3.6999 to a trough of $1.2589, indicating an -3.53% surge from the present price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.9523 | $1.2589 | $1.0406 | -24.03% |
| February, 2026 | $2.3391 | $2.2174 | $1.654 | -8.99% |
| March, 2026 | $2.5659 | $2.4625 | $2.1442 | -0.16% |
| April, 2026 | $2.3143 | $2.4126 | $2.645 | -9.95% |
| May, 2026 | $2.3311 | $2.386 | $2.1777 | -9.30% |
| June, 2026 | $2.0379 | $2.0979 | $2.0362 | -20.71% |
| July, 2026 | $2.3063 | $2.1995 | $2.236 | -10.26% |
| August, 2026 | $3.7381 | $2.458 | $2.8214 | +45.45% |
| September, 2026 | $3.7115 | $3.7215 | $3.6999 | +44.42% |
| October, 2026 | $3.4683 | $3.5059 | $3.6334 | +34.95% |
| November, 2026 | $2.4451 | $2.7351 | $3.37 | -4.86% |
| December, 2026 | $1.5935 | $1.7335 | $1.6968 | -37.99% |
Rani Therapeutics Holdings Inc Stock (RANI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Rani Therapeutics Holdings Inc (RANI) is $6.9716, with a high forecast of $13.72 and a low forecast of $0.2237. This indicates an +171.27% increase from the last price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0603 | $1.5002 | $1.3486 | -58.74% |
| February, 2027 | $0.9671 | $1.031 | $1.2337 | -62.37% |
| March, 2027 | $0.7155 | $1.0987 | $1.0639 | -72.16% |
| April, 2027 | $2.1577 | $0.8472 | $4.4311 | -16.04% |
| May, 2027 | $5.0568 | $1.626 | $4.6734 | +96.76% |
| June, 2027 | $3.5863 | $0.2237 | $12.25 | +39.55% |
| July, 2027 | $7.2828 | $1.8629 | $13.72 | +183.38% |
| August, 2027 | $3.3708 | $0.9206 | $8.2319 | +31.16% |
| September, 2027 | $1.8777 | $3.2543 | $5.6423 | -26.94% |
| October, 2027 | $6.0212 | $2.6081 | $4.1012 | +134.29% |
| November, 2027 | $5.9548 | $5.7014 | $5.0046 | +131.70% |
| December, 2027 | $7.4117 | $6.9883 | $6.0624 | +188.39% |
Rani Therapeutics Holdings Inc Stock (RANI) Price Forecast for 2028
In 2028, Rani Therapeutics Holdings Inc (RANI) is projected to reach an average price of $9.0338, with a high projection of $10.81 and a low estimate of $7.2592. This indicates an +251.51% rise from the last price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.1252 | $7.4985 | $6.9752 | +216.16% |
| February, 2028 | $8.0588 | $9.052 | $7.8486 | +213.57% |
| March, 2028 | $8.6457 | $8.0723 | $8.5655 | +236.41% |
| April, 2028 | $6.5792 | $7.2592 | $7.2292 | +156.00% |
| May, 2028 | $8.7062 | $7.8128 | $6.9362 | +238.76% |
| June, 2028 | $8.8497 | $8.4458 | $8.2145 | +244.35% |
| July, 2028 | $10.25 | $8.6398 | $8.1332 | +298.96% |
| August, 2028 | $10.36 | $10.70 | $10.81 | +303.12% |
| September, 2028 | $8.4737 | $8.6437 | $8.4135 | +229.72% |
| October, 2028 | $10.18 | $9.1405 | $9.8422 | +296.00% |
| November, 2028 | $10.10 | $9.754 | $9.7142 | +293.16% |
| December, 2028 | $8.9677 | $9.5476 | $9.6675 | +248.94% |
Rani Therapeutics Holdings Inc Stock (RANI) Price Forecast for 2029
The 2029 price forecast for Rani Therapeutics Holdings Inc Stock (RANI) is $8.3506 on average, with a high prediction of $9.5243 and a low estimate of $7.1768. This represents an +224.92% increase from the previous price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.3146 | $8.7179 | $8.6311 | +262.44% |
| February, 2029 | $9.5082 | $9.4348 | $8.968 | +269.97% |
| March, 2029 | $9.5417 | $9.5349 | $9.2516 | +271.27% |
| April, 2029 | $8.6152 | $9.1952 | $9.5243 | +235.22% |
| May, 2029 | $8.8722 | $8.9597 | $8.8154 | +245.22% |
| June, 2029 | $8.3857 | $8.4457 | $8.4806 | +226.29% |
| July, 2029 | $8.5092 | $8.4925 | $8.3906 | +231.10% |
| August, 2029 | $9.6512 | $8.4126 | $8.7828 | +275.53% |
| September, 2029 | $9.4847 | $9.5397 | $9.4796 | +269.05% |
| October, 2029 | $8.9466 | $8.9842 | $9.3031 | +248.12% |
| November, 2029 | $7.7302 | $8.0202 | $8.80 | +200.78% |
| December, 2029 | $6.7837 | $7.1768 | $6.9336 | +163.96% |
Rani Therapeutics Holdings Inc Stock (RANI) Price Forecast for 2030
Rani Therapeutics Holdings Inc Stock (RANI) is expected to reach an average price of $9.3099 in 2030, with a high forecast of $16.34 and a low forecast of $2.2846. This signifies an +262.25% surge from the last price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.9106 | $6.3505 | $6.3071 | +129.99% |
| February, 2030 | $5.6242 | $5.6881 | $5.9874 | +118.84% |
| March, 2030 | $5.8177 | $5.7075 | $5.5277 | +126.37% |
| April, 2030 | $1.8613 | $2.3013 | $5.0311 | -27.58% |
| May, 2030 | $16.67 | $2.2846 | $16.34 | +548.64% |
| June, 2030 | $11.26 | $15.55 | $14.55 | +338.15% |
| July, 2030 | $3.8958 | $4.7157 | $4.5106 | +51.59% |
| August, 2030 | $14.36 | $12.05 | $13.45 | +458.61% |
| September, 2030 | $13.50 | $14.05 | $14.84 | +425.15% |
| October, 2030 | $16.57 | $13.30 | $14.65 | +544.82% |
| November, 2030 | $16.31 | $16.11 | $15.51 | +534.71% |
| December, 2030 | $16.90 | $17.15 | $16.23 | +557.68% |
3.35%
0.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):